Koushyar S, Uysal Onganer P, Jiang W, Dart D. Prohibitin Links Cell Cycle, Motility and Invasion in Prostate Cancer Cells. Int J Mol Sci. 2023;24: pubmed publisher

Matsuoka K, Bakiri L, Wolff L, Linder M, Mikels Vigdal A, Patino Garcia A, et al. Wnt signaling and Loxl2 promote aggressive osteosarcoma. Cell Res. 2020;: pubmed publisher

Vallon M, Yuki K, Nguyen T, Chang J, Yuan J, Siepe D, et al. A RECK-WNT7 Receptor-Ligand Interaction Enables Isoform-Specific Regulation of Wnt Bioavailability. Cell Rep. 2018;25:339-349.e9 pubmed publisher

Karthikeyan S, Russo A, DEAN M, Lantvit D, Endsley M, Burdette J. Prolactin signaling drives tumorigenesis in human high grade serous ovarian cancer cells and in a spontaneous fallopian tube derived model. Cancer Lett. 2018;433:221-231 pubmed publisher

Glaeser K, Urban M, Fenech E, Voloshanenko O, Kranz D, Lari F, et al. ERAD-dependent control of the Wnt secretory factor Evi. EMBO J. 2018;37: pubmed publisher

Voloshanenko O, Gmach P, Winter J, Kranz D, Boutros M. Mapping of Wnt-Frizzled interactions by multiplex CRISPR targeting of receptor gene families. FASEB J. 2017;31:4832-4844 pubmed publisher

Najdi R, Proffitt K, Sprowl S, Kaur S, Yu J, Covey T, et al. A uniform human Wnt expression library reveals a shared secretory pathway and unique signaling activities. Differentiation. 2012;84:203-13 pubmed publisher